» Articles » PMID: 37576848

Barriers and Facilitators of Colorectal Cancer Screening Using the 5As Framework: A Systematic Review of US Studies

Overview
Journal Prev Med Rep
Date 2023 Aug 14
PMID 37576848
Authors
Affiliations
Soon will be listed here.
Abstract

Despite clear evidence that regular screening reduces colorectal cancer (CRC) mortality and the availability of multiple effective screening options, CRC screening continues to be underutilized in the US. A systematic literature search of four databases - Ovid, Medline, EBSCHOhost, and Web of Science - was conducted to identify US studies published after 2017 that reported on barriers and facilitators to CRC screening adherence. Articles were extracted to categorize relevant CRC screening barriers or facilitators that were assessed against CRC screening outcomes using the 5As dimensions: Access, Affordability, Acceptance, Awareness, Activation. Sixty-one studies were included. Fifty determinants of screening within the 5As framework and two additional dimensions including Sociodemographics and Health Status were identified. The Sociodemographics, Access, and Affordability dimensions had the greatest number of studies included. The most common factor in the Access dimension was contact with healthcare systems, within the Affordability dimension was insurance, within the Awareness dimension was knowledge CRC screening, within the Acceptance dimension was health beliefs, within the Activation dimension was prompts and reminders, within the Sociodemographics dimension was race/ethnicity, and among the Health Status dimension was chronic disease history. Among all studies, contact with healthcare systems, insurance, race/ethnicity, age, and education were the most common factors identified. CRC screening barriers and facilitators were identified across individual, clinical, and sociocontextual levels. Interventions that consider multilevel strategies will most effectively increase CRC screening adherence.

Citing Articles

Legal-involved veterans are less likely to receive guideline-concordant colorectal cancer screening.

Nieser K, Harris A, Binswanger I, Clark S, Finlay A BMC Health Serv Res. 2025; 25(1):333.

PMID: 40038662 PMC: 11877804. DOI: 10.1186/s12913-025-12490-6.


Predictors of stages of adoption of colorectal cancer screening among adults attending primary healthcare centers in Turkey.

Donmez E, Toptaner N, Ata E, Dulger Z, Acar O J Egypt Public Health Assoc. 2025; 100(1):4.

PMID: 40032745 PMC: 11876507. DOI: 10.1186/s42506-025-00185-z.


Body mass index and colorectal cancer screening among cancer survivors: the role of sociodemographic characteristics.

Meng-Han T, Elinita P, Marlo V, Jie C Cancer Causes Control. 2025; .

PMID: 39939485 DOI: 10.1007/s10552-025-01970-z.


Colorectal Cancer Racial Equity Post Volume, Content, and Exposure: Observational Study Using Twitter Data.

Tong C, Margolin D, Niederdeppe J, Chunara R, Liu J, Jih-Vieira L J Med Internet Res. 2025; 27:e63864.

PMID: 39899839 PMC: 11833265. DOI: 10.2196/63864.


Optimizing tracking and completion of follow-up colonoscopy after abnormal stool tests at health systems participating in the Centers for Disease Control and Prevention's Colorectal Cancer Control Program.

Subramanian S, Tangka F, Hoover S, Mathews A, Redwood D, Smayda L Cancer Causes Control. 2024; 35(11):1467-1476.

PMID: 39107449 PMC: 11670815. DOI: 10.1007/s10552-024-01898-w.


References
1.
Schreuders E, Ruco A, Rabeneck L, Schoen R, Sung J, Young G . Colorectal cancer screening: a global overview of existing programmes. Gut. 2015; 64(10):1637-49. DOI: 10.1136/gutjnl-2014-309086. View

2.
Marrie R, Salter A, Tyry T, Fox R, Cutter G . Preferred sources of health information in persons with multiple sclerosis: degree of trust and information sought. J Med Internet Res. 2013; 15(4):e67. PMC: 3650929. DOI: 10.2196/jmir.2466. View

3.
Lee E, Natipagon-Shah B, Sangsanoi-Terkchareon S, Warda U, Lee S . Factors Influencing Colorectal Cancer Screening Among Thais in the U.S. J Community Health. 2018; 44(2):230-237. DOI: 10.1007/s10900-018-0578-x. View

4.
Jung M, Holt C, Ng D, Sim H, Lu X, Le D . The Chinese and Korean American immigrant experience: a mixed-methods examination of facilitators and barriers of colorectal cancer screening. Ethn Health. 2017; 23(8):847-866. PMC: 5573633. DOI: 10.1080/13557858.2017.1296559. View

5.
Green B, West I, Baldwin L, Schwartz M, Coury J, Coronado G . Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program. J Community Health. 2020; 45(5):916-921. DOI: 10.1007/s10900-020-00809-9. View